Causes and impact of delays during the COVID‐19 pandemic on head and neck cancer diagnosis DOI Creative Commons

Maru Gete,

Shao Hui Huang, Jolie Ringash

et al.

Head & Neck, Journal Year: 2024, Volume and Issue: 46(9), P. 2197 - 2205

Published: April 25, 2024

Abstract Background The causes for delays during the COVID19 pandemic and their impact on head neck cancer (HNC) diagnosis staging are not well described. Methods Two cohorts were defined a priori review analysis—a Pre‐Pandemic cohort (June 1 to December 31, 2019) Pandemic 2020). Delays categorized as COVID‐19 related or not, clinician, patient, policy related. Results A total of 638 HNC patients identified including 327 in Cohort 311 Cohort. Patients had more N2‐N3 category (41% vs. 33%, p = 0.03), T3‐T4 (63% 50%, 0.002), stage III‐IV (71% 58%, < 0.001) disease. Several intervals treatment pathway significantly longer compared cohort. Among cohort, 146 (47%) experienced delay, with 112 pandemic; 80 (71%) clinician related, 15 (13%) patient 17 (15%) Conclusions higher disease at along diagnostic pathway, factors being most common cause delay.

Language: Английский

Alterations in Cancer Treatment During the First Year of the COVID-19 Pandemic in the US DOI Creative Commons
Lauren M. Janczewski,

Joseph Cotler,

Ryan P. Merkow

et al.

JAMA Network Open, Journal Year: 2023, Volume and Issue: 6(10), P. e2340148 - e2340148

Published: Oct. 30, 2023

Importance The COVID-19 pandemic created challenges to the evaluation and treatment of cancer, abrupt resource diversion toward patients with put cancer on hold for many patients. Previous reports have shown substantial declines in screening diagnoses 2020; however, extent which delivery care was altered remains unclear. Objective To assess alterations US during first year pandemic. Design, Setting, Participants This retrospective cohort study used data from National Cancer Database (NCDB) older than 18 years newly diagnosed January 1, 2018, December 31, 2020. Main Outcomes Measures main outcomes were accessibility (time treatment, travel distance, multi-institutional care), availability (proportional changes between years), utilization (reductions by modality, hospital type) 2020 compared 2018 2019. Autoregressive models forecasted expected findings based observations prior years. Results Of 1 229 654 identified NCDB 2020, 074 225 treated representing a 16.8% reduction what expected. Patients predominately female (53.8%), median age 66 (IQR, 57-74 similar demographics Median time diagnosis 26 days 0-36 days) distance 11.1 miles 5.0-25.3 miles), In fewer traveled longer distances (20.2% traveling &amp;gt;35 miles). proportions chemotherapy (32.0%), radiation (29.5%), surgery (57.1%) those Overall, 146 805 underwent surgery, 80 480 received radiation, 68 014 chemotherapy. Academic hospitals experienced greatest decrease approximately 484 (−19.0%) per 99 (−12.6%) at community 110 (−12.8%) integrated networks. Conclusions Relevance found that among access remained intact; reductions varied across modalities greater academic networks values. These results suggest resilience service lines frame economic losses

Language: Английский

Citations

9
Addressing the health human resources crisis: Strategies for retaining women health care professionals in organizations DOI Creative Commons
Abi Sriharan, Nigar Sekercioglu, Whitney Berta

et al.

PLoS ONE, Journal Year: 2024, Volume and Issue: 19(6), P. e0293107 - e0293107

Published: June 13, 2024

Globally, healthcare systems are contending with a pronounced health human resource crisis marked by elevated rates of burnout, heightened job transitions, and an escalating demand for the limited supply existing workforce. This detrimentally affects quality patient care, contributing to long wait times, decreased satisfaction, frequency safety incidents medical errors. In response demand, organizations proactively exploring solutions retain their With women comprising over 70% resources, this study seeks gain insight into unique experiences professionals on frontlines develop conceptual framework aimed at facilitating in effectively supporting retention advancement frontline roles. We used grounded theory qualitative study. From January 2023 May 2023, we conducted individual semi-structured interviews 27 HCWs working Canada representing diverse backgrounds. The data underwent thematic analysis, which involved identifying comprehending recurring patterns across information elucidate emerging themes. Our analysis found that organizational, professional, personal factors shape women’s intentions leave Reevaluating organizational strategies related workforce, fostering positive work culture, building capacity management create supportive environment can collectively transform environment. By creating conditions enable perform find satisfaction professional roles, enhance ability valuable talent.

Language: Английский

Citations

3
Cancer Care During COVID-19—A Shock to the System DOI Creative Commons
Joseph M. Unger

JAMA Network Open, Journal Year: 2022, Volume and Issue: 5(4), P. e228864 - e228864

Published: April 25, 2022

Meghan J. Walker, PhD; Jonathan Wang, MASc; Joshua Mazuryk, BSc; Siew-Mei Skinner, BMRSc; Olivia Meggetto, MSc; Eta Ashu, Steven Habbous, Narges Nazeri Rad, Gabriela Espino-Hernández, Ryan Wood, MHS; Munaza Chaudhry, Saba Vahid, Julia Gao, Daniela Gallo-Hershberg, BScPhm, PharmD; Eric Gutierrez, Claudia Zanchetta, MN(ACNP); Deanna Langer, Victoria Zwicker, MPH; Michelle Rey, Martin C. Tammemägi, Jill Tinmouth, MD, Rachel Kupets, Anna M. Chiarelli, Simron Singh, Padraig Warde, MD; Leta Forbes, Julian Dobranowski, Irish, Linda Rabeneck, Cancer Care Ontario COVID-19 Impact Working Group; Chamila Adhihetty; Jaclyn Beca; Diane Burns; Catherine Chan; Kelvin KW Lauren Chun; Melissa Coulson; Gail E Darling; Prithwish De; Dong; Dubé; Maria Eberg; Samantha Fienberg; Colleen Fox; Sophie Foxcroft; Ron Fung; Scott Gavura; Natasha Gray; Sherrie Hertz; Brian Ho; Claire M Holloway; Amber Hunter; Nathaniel Jembere; Tina Karapetyan; Shivali Kaushal; Mary J King; Ordeena Linton; Aisha K Lofters; Andrea Mackesy; Faisal Majeed; Jessica Mann; Pamela MacCrostie; Garth Matheson; Bronwen R McCurdy; Elaine Meertens; Reeza Menalo; Lisa Milgram; Nicole Moleschi; Elena Mow; Joan Murphy; Rohini Naipaul; Karen Nguyen; O'Grady; Aaron Pollett; Elizabeth Quilliam; Dimpho Radebe; Jocelyn Sacco; Nancy Shukla; Vicky Simanovski; Steve Scott; Xiaochen Tai; Cristina Tassone; Arany Theivendram; Rebecca Truscott; Christa Wang; Audrey Wong; Lyndee Yeung; Marta Yurcan

Language: Английский

Citations

13
Up-to-date on cancer screening among Ontario patients seen by walk-in clinic physicians: A retrospective cohort study DOI Creative Commons
Aïsha Lofters, Christine Salahub, Peter C. Austin

et al.

Preventive Medicine, Journal Year: 2023, Volume and Issue: 172, P. 107537 - 107537

Published: May 6, 2023

Walk-in clinics are typically viewed as high-volume locations for managing acute issues but also may serve a location primary care, including cancer screening, patients without family physician. In this population-based cohort study, we compared breast, cervical and colorectal screening up-to-date status people living in the Canadian province of Ontario who were formally enrolled to physician versus those not had at least one encounter with walk-in clinic previous year. Using provincial administrative databases, created two mutually exclusive groups: i) physician, ii) visit from April 1, 2019 March 31, 2020. We up date three screenings 2020 among screen-eligible people. found that seen year consistently less likely be on than Ontarians (46.1% vs. 67.4% 45.8% cervical, 49.5% 73.1% colorectal). They more foreign-born live structurally marginalized neighbourhoods. New methods needed enable reliant address urgent need care providers deliver comprehensive, longitudinal care.

Language: Английский

Citations

7
Causes and impact of delays during the COVID‐19 pandemic on head and neck cancer diagnosis DOI Creative Commons

Maru Gete,

Shao Hui Huang, Jolie Ringash

et al.

Head & Neck, Journal Year: 2024, Volume and Issue: 46(9), P. 2197 - 2205

Published: April 25, 2024

Abstract Background The causes for delays during the COVID19 pandemic and their impact on head neck cancer (HNC) diagnosis staging are not well described. Methods Two cohorts were defined a priori review analysis—a Pre‐Pandemic cohort (June 1 to December 31, 2019) Pandemic 2020). Delays categorized as COVID‐19 related or not, clinician, patient, policy related. Results A total of 638 HNC patients identified including 327 in Cohort 311 Cohort. Patients had more N2‐N3 category (41% vs. 33%, p = 0.03), T3‐T4 (63% 50%, 0.002), stage III‐IV (71% 58%, < 0.001) disease. Several intervals treatment pathway significantly longer compared cohort. Among cohort, 146 (47%) experienced delay, with 112 pandemic; 80 (71%) clinician related, 15 (13%) patient 17 (15%) Conclusions higher disease at along diagnostic pathway, factors being most common cause delay.

Language: Английский

Citations

2